FDA's new expert panels are rife with financial conflicts and fringe views
Read full article: FDA's new expert panels are rife with financial conflicts and fringe viewsA series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules and promoting fringe views about antidepressants and other products.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/4RDLBSWRKBE4BIFCIYZSJOMTVA.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/GNEQQ7X5IBGFJFKBDEHF6YEW4U.jpg)